Paper List

Sara Pires, Lapo Mughini-Gras, Sandra Hoffmann, Kunihiro Kubota, Shannon Majowicz, Martyn Kirk, Lucy Robertson, Paul Torgerson, Lea Jakobsen, Antonio Agudo, Li Bai, Tety Rachmawati, Yuki Minato, Charlee Roberts, Arie Havelaar, Brecht Devleesschauwer, Elisa Benincà, Robin Lake, Tine Hald, Roger Cooke, Willy Aspinall, Gabriela Nane

Identifying the sources of foodborne diseases is crucial for guiding national food safety strategies and supporting policies that promote safe and sustainable diets. We present global estimates of the...

Faraz Saif, Fakhra Nain Qureshi, Azaz Ahmad, Fakeeda Durrani, Noor Ul Ain Azam, Imad Ullah, Zia Ud Din Ahmed, Asif Riaz Khan

Purpose The neutrophil-to-lymphocyte ratio (NLR) is an emerging biomarker for predicting febrile neutropenia (FN) in cancer patients. This study aimed to evaluate the association between pre-treatment...

Xu Zheng, Li Li, HongZhi LIU, Peng Wang, LiJun Tian

Objective：To evaluate the efficacy of combining Case-based learning (CBL) with micro-video teaching in oncology education, specifically focusing on immune checkpoint inhibitors (ICIs) therapy. Methods...

Simona Pagliuca, Vincent Alcazer, Mélanie Gaudfrin, Nicole Raus, Anne Huynh, Raynier Devillier, Arda Dumaz, Ashwin Kishtagari, Lukasz Gondek, Mark Juckett, Suresh Kumar Balasubramanian, Marie Robin, Ibrahim Yakoub-Agha, Edouard Forcade, Claude Eric Bulabois, Jean-Baptiste Méar, Patrice Chevallier, Cristina Castilla Llorente, Xavier Poiré, Michaël Loschi, Johan Maertens, Stéphanie Nguyen, Frédéric Baron, Etienne Daguindau, Natacha Maillard, Florent Malard, Alice Aarnink, Maud D’Aveni-Piney, Marie Thérèse Rubio, Francesca Ferraro, Valeria Visconte, Tobias Lenz, Carmelo Gurnari, Jaroslaw Maciejewski

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative option for many hematologic malignancies, yet transplant-related toxicity and relapse continue to constrain long-term...

Tânia R. Dias, Beatriz Almeida, Pedro Cruz, Mário Sousa Pimenta, Manuel Morais, Luís Rocha, Jose Manuel Martinez, Ana Luísa Teixeira, Júlio Oliveira, Francisca Dias, Rui Medeiros

Cancer patients are at increased risk of severe COVID-19 outcomes. Understanding their immunological response to SARS-CoV-2 mRNA vaccination is essential for identifying molecular biomarkers that can ...

William Foulkes, Kenzie Melvill, Leora Witkowski, Céline Domecq, Nancy Hamel, Justin Mayers, Sofia Maia, Manuel Teixeira, Inês Francisco, Cristina Albuquerque, Olivia Tan, Kevin McDonnell, Alexandra Capasso, George Chong, Victoria Marcus, Carla Pinto

In certain populations, founder pathogenic variants are a common cause of Lynch syndrome. Here, we report the identification of a novel founder variant, NM_000179.3 (MSH6):c.2061T > G (p.Cys687Trp). O...

Atantra Das Gupta

Traditional approaches to anticancer dosing typically rely on fixed protocols that often overlook how patients respond differently to treatment. This can limit both effectiveness and safety. In this w...